PREVIOUS
✖
‘DESREM’
July 9 , 2020
1380 days
708
0
- It is the generic version of Gilead Sciences Remdesivir drug.
- It is for the treatment of COVID - 19 positive patients in India.
- The Global pharmaceutical company Mylan N.V was given approval by the Drug Controller General of India (DCGI).
- Mylan N.V is currently the second-largest company in the World for the manufacturing of generic drugs.
- DESREM is the third generic version of Remdesivir to get DCGI approval for sale in India.
- Earlier, the generic versions of Indian pharmaceutical companies – Cipla’s CIPREMI and Hetero’s COVIFOR’ has got DCGI approval.
- Japan was the first country to approve Remdesivir drug as a treatment for COVID-19.
Leave a Reply
Your Comment is awaiting moderation.